Medpace Holdings, Inc. (MEDP) › Cash & EquivalentsMedpace Holdings, Inc. (MEDP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2015: $14.88M2016: $37.10M2017: $26.48M2018: $23.27M2019: $131.92M2020: $277.77M2021: $461.30M2022: $28.27M2023: $245.45M2024: $669.44M2025: $497.05M$497.05M2015Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$497.05M-25.8%2024$669.44M+172.7%2023$245.45M+768.4%2022$28.27M-93.9%2021$461.30M+66.1%2020$277.77M+110.6%2019$131.92M+466.8%2018$23.27M-12.1%2017$26.48M-28.6%2016$37.10M+149.3%2015$14.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share